Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/14/2009 | EP2014650A1 Process and intermediate for the production of an intermediate in the production of montelukast |
01/14/2009 | EP2013181A1 Pyridyl compounds |
01/14/2009 | EP2013178A1 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
01/14/2009 | EP2013170A1 4-squarylpiperazine derivatives as antiviral agents |
01/14/2009 | EP2012778A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
01/14/2009 | EP1874762B1 Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide |
01/14/2009 | EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
01/14/2009 | EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups |
01/14/2009 | EP1560584B1 Fab i inhibitors |
01/14/2009 | EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors |
01/14/2009 | EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
01/14/2009 | EP1323716B1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
01/14/2009 | CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
01/14/2009 | CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
01/14/2009 | CN101346349A Process for the production of ezetimibe and intermediates used in this proces |
01/14/2009 | CN101346243A Optical recording medium and azacyanine dye |
01/14/2009 | CN101346141A Quinoline derivatives useful in the treatment of MGLUR5 receptor-mediated disorders |
01/14/2009 | CN101343251A Thrombopoietin mimetics |
01/14/2009 | CN101343250A Thrombopoietin mimetics |
01/14/2009 | CN101342169A Thrombopoietin mimetics |
01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
01/14/2009 | CN100451014C Process for making chiral 1,4-disubstituted piperazines |
01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
01/13/2009 | US7478376 Computer program code size partitioning method for multiple memory multi-processing systems |
01/13/2009 | US7476746 PPAR active compounds |
01/13/2009 | US7476741 Treating proliferative disorders such as cancer, autoimmune or inflammatory diseases such as psoriasis; e.g. 4-(3-Bromo-4,5-dimethoxyphenyl)-3-cyano-7-dimethylamino-4H-chromene; use with known anticancer drugs or radiotherapy |
01/13/2009 | US7476727 Conjugates of mycophenolic acid |
01/13/2009 | US7476690 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
01/13/2009 | US7476688 Cyclic amidine derivatives |
01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
01/13/2009 | US7476685 Pyridine carboxamide derivatives and their use as pesticides |
01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
01/13/2009 | US7476675 Quinolinone derivatives and uses thereof |
01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
01/13/2009 | US7476664 Bis-2-difluoro-pyrrolo[2,1-C][1,4]benzodiazepine dimers |
01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
01/08/2009 | WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers |
01/08/2009 | WO2009006413A1 Substituted pyrrolidines |
01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
01/08/2009 | WO2009005024A1 Method for producing optically active amine |
01/08/2009 | WO2009005002A1 Quinolone derivative |
01/08/2009 | WO2009004383A2 Aza-bicyclohexane compounds useful as anticoagulants |
01/08/2009 | WO2009004356A1 Phthalazinone derivatives as inhibitors of parp-1 |
01/08/2009 | WO2009003868A2 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
01/08/2009 | WO2009003861A1 Imidazole derivatives as ccr2 receptor antagonists |
01/08/2009 | WO2008142720A3 Quinazolin-oxime derivatives as hsp90 inhibitors |
01/08/2009 | WO2008141462A9 Novel case of renin inhibitors |
01/08/2009 | WO2008128750A3 Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof |
01/08/2009 | WO2008063548A3 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents |
01/08/2009 | WO2008057254A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
01/08/2009 | US20090012309 Chemical compounds |
01/08/2009 | US20090012302 Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first ph and a solid material for nucleic acid isolation used for the method |
01/08/2009 | US20090012290 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
01/08/2009 | US20090012148 Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
01/08/2009 | US20090012081 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
01/08/2009 | US20090012073 N-aroyl cyclic amines |
01/08/2009 | US20090012070 Pesticidal heterocycles |
01/08/2009 | US20090012069 Novel Antidiabetic Compounds |
01/08/2009 | DE102006014324B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
01/08/2009 | DE102006014319B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
01/08/2009 | CA2692145A1 Antiviral compounds |
01/08/2009 | CA2691662A1 Imidazole derivatives as ccr2 receptor antagonists |
01/08/2009 | CA2691459A1 Phthalazinone derivatives as inhibitors of parp-1 |
01/08/2009 | CA2691082A1 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
01/08/2009 | CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
01/07/2009 | EP2010527A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity |
01/07/2009 | EP2010526A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands |
01/07/2009 | EP2010521A1 Indazole compounds and methods for inhibition of cdc7 |
01/07/2009 | EP2010520A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases |
01/07/2009 | EP2010519A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
01/07/2009 | EP2010515A1 2-(pyridin-2-yl)-pyrimidines for use as fungicides |
01/07/2009 | EP2010514A1 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides |
01/07/2009 | EP2010509A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
01/07/2009 | EP2010506A1 Diazepan derivatives modulators of chemokine receptors |
01/07/2009 | EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
01/07/2009 | EP2010502A1 Pyrimidine derivatives for the treatment of amyloid-related diseases |
01/07/2009 | EP2010485A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists |
01/07/2009 | EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol |
01/07/2009 | EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
01/07/2009 | EP1569916B1 Substituted aralkyl derivatives |
01/07/2009 | EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases |
01/07/2009 | EP1470113B1 Pyrimidinone viral polymerase inhibitors |
01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
01/07/2009 | EP1001939B1 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides |
01/07/2009 | CN101341149A Chromane substituted benzimidazoles and their use as acid pump inhibitors |
01/07/2009 | CN101341136A Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
01/07/2009 | CN101341133A Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
01/07/2009 | CN101341131A Imidazoles as gaba-b receptor modulators |
01/07/2009 | CN101341130A Imidazole derivatives for the treatment of gastrointestinal disorders |
01/07/2009 | CN101341129A Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
01/07/2009 | CN101341128A Pyrazoles for the treatment of gerd and ibs |
01/07/2009 | CN101341127A 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
01/07/2009 | CN101341126A Antibacterial active 5-chinolin derivative |
01/07/2009 | CN101341123A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |